CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors

Sophie Archer(Babraham Institute), Andrew J. Pierce(University of Kentucky)
Clinical Cancer Research
April 9, 2024
Cited by 13


Related Papers